TY - JOUR
T1 - Demonstration of direct binding of cIAP1 degradation-promoting bestatin analogs to BIR3 domain
T2 - Synthesis and application of fluorescent bestatin ester analogs
AU - Sato, Shinichi
AU - Aoyama, Hiroshi
AU - Miyachi, Hiroyuki
AU - Naito, Mikihiko
AU - Hashimoto, Yuichi
N1 - Funding Information:
We are grateful to Nippon Kayaku Co. for providing MeBS. The work described in this letter was partially supported by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science.
PY - 2008/6/1
Y1 - 2008/6/1
N2 - Overexpression of cIAP1 correlates with resistance to radiotherapy and chemotherapy in various cancers. Recently, we reported that a class of bestatin ester analogs represented by MeBS (2) destabilized and promoted the degradation of cIAP1 through auto-ubiquitination, and thereby sensitized cancer cells to apoptosis. Herein, we present chemical evidence that bestatin ester analogs directly interact with the cIAP1-BIR3 domain by means of fluorescence polarization assay and photoaffinity labeling assay using fluorescent probes.
AB - Overexpression of cIAP1 correlates with resistance to radiotherapy and chemotherapy in various cancers. Recently, we reported that a class of bestatin ester analogs represented by MeBS (2) destabilized and promoted the degradation of cIAP1 through auto-ubiquitination, and thereby sensitized cancer cells to apoptosis. Herein, we present chemical evidence that bestatin ester analogs directly interact with the cIAP1-BIR3 domain by means of fluorescence polarization assay and photoaffinity labeling assay using fluorescent probes.
KW - Bestatin
KW - BIR3 domain
KW - cIAP1
KW - Fluorescence polarization
KW - Photoaffinity labeling
UR - http://www.scopus.com/inward/record.url?scp=44149100029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44149100029&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2008.04.031
DO - 10.1016/j.bmcl.2008.04.031
M3 - Article
C2 - 18448338
AN - SCOPUS:44149100029
SN - 0960-894X
VL - 18
SP - 3354
EP - 3358
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 11
ER -